Beyond Medical Technologies Announces Corporate Name Change to Republic Technologies
Beyond Medical Technologies (CSE: DOCT) has announced its corporate name change to Republic Technologies Inc., effective July 15th, 2025. The company's common shares will maintain their trading symbol "DOCT" on the Canadian Securities Exchange, with a new CUSIP (760801100) and ISIN (CA7608011002).
Republic Technologies focuses on developing smart contract-based attestation products and operating Ethereum validators through ETH staking. The company maintains ETH as its primary treasury asset and aims to expand its holdings alongside infrastructure growth. The new name reflects the company's commitment to decentralization, transparency, and democratized access to secure systems.
Beyond Medical Technologies (CSE: DOCT) ha annunciato il cambio del nome aziendale in Republic Technologies Inc., con effetto dal 15 luglio 2025. Le azioni ordinarie della società manterranno il simbolo di negoziazione "DOCT" sulla Canadian Securities Exchange, con un nuovo CUSIP (760801100) e ISIN (CA7608011002).
Republic Technologies si concentra sullo sviluppo di prodotti di attestazione basati su smart contract e sulla gestione di validatori Ethereum tramite staking di ETH. La società mantiene ETH come principale attività di tesoreria e punta ad ampliare le proprie partecipazioni parallelamente alla crescita dell'infrastruttura. Il nuovo nome riflette l'impegno dell'azienda verso la decentralizzazione, la trasparenza e l'accesso democratizzato a sistemi sicuri.
Beyond Medical Technologies (CSE: DOCT) ha anunciado el cambio de nombre corporativo a Republic Technologies Inc., efectivo a partir del 15 de julio de 2025. Las acciones comunes de la compañía mantendrán su símbolo de cotización "DOCT" en la Canadian Securities Exchange, con un nuevo CUSIP (760801100) e ISIN (CA7608011002).
Republic Technologies se enfoca en desarrollar productos de atestación basados en contratos inteligentes y en operar validadores de Ethereum mediante staking de ETH. La compañía mantiene ETH como su principal activo en tesorería y busca expandir sus tenencias junto con el crecimiento de la infraestructura. El nuevo nombre refleja el compromiso de la empresa con la descentralización, la transparencia y el acceso democratizado a sistemas seguros.
Beyond Medical Technologies (CSE: DOCT)는 2025년 7월 15일부터 회사명을 Republic Technologies Inc.로 변경한다고 발표했습니다. 회사의 보통주는 캐나다 증권 거래소에서 "DOCT"라는 거래 심볼을 유지하며, 새로운 CUSIP(760801100) 및 ISIN(CA7608011002)를 부여받습니다.
Republic Technologies는 스마트 계약 기반 증명 제품 개발과 ETH 스테이킹을 통한 이더리움 검증자 운영에 주력하고 있습니다. 회사는 ETH를 주요 자산으로 보유하며, 인프라 확장과 함께 자산을 늘려나갈 계획입니다. 새로운 이름은 분산화, 투명성 및 안전한 시스템에 대한 민주적 접근에 대한 회사의 의지를 반영합니다.
Beyond Medical Technologies (CSE : DOCT) a annoncé le changement de son nom corporatif pour Republic Technologies Inc., effectif à partir du 15 juillet 2025. Les actions ordinaires de la société conserveront leur symbole de négociation "DOCT" sur la Canadian Securities Exchange, avec un nouveau CUSIP (760801100) et ISIN (CA7608011002).
Republic Technologies se concentre sur le développement de produits d'attestation basés sur des contrats intelligents et l'exploitation de validateurs Ethereum via le staking d'ETH. L'entreprise maintient l'ETH comme principal actif de trésorerie et vise à étendre ses avoirs parallèlement à la croissance de son infrastructure. Le nouveau nom reflète l'engagement de la société envers la décentralisation, la transparence et l'accès démocratisé à des systèmes sécurisés.
Beyond Medical Technologies (CSE: DOCT) hat die Änderung des Firmennamens zu Republic Technologies Inc. bekanntgegeben, die am 15. Juli 2025 wirksam wird. Die Stammaktien des Unternehmens behalten ihr Handelssymbol "DOCT" an der Canadian Securities Exchange bei, mit einer neuen CUSIP (760801100) und ISIN (CA7608011002).
Republic Technologies konzentriert sich auf die Entwicklung von auf Smart Contracts basierenden Attestationsprodukten und den Betrieb von Ethereum-Validatoren durch ETH-Staking. Das Unternehmen hält ETH als Hauptvermögenswert in der Treasury und plant, seine Bestände parallel zum Ausbau der Infrastruktur zu erweitern. Der neue Name spiegelt das Engagement des Unternehmens für Dezentralisierung, Transparenz und demokratisierten Zugang zu sicheren Systemen wider.
- None.
- None.
Vancouver, British Columbia--(Newsfile Corp. - July 16, 2025) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (the "Company") is pleased to announce that it has changed its name to Republic Technologies Inc. ("Republic"), effective on July 15th, 2025.
The new CUSIP for the Company's common shares will be 760801100 and the new ISIN number will be CA7608011002.
The name change highlights the Company's commitment toward leveraging transformative technologies to serve the public good. Republic develops smart contract-based attestation products and operates Ethereum validators by staking ETH to confirm transactions, produce blocks, and maintain consensus within the Proof-of-Stake (PoS) system. Republic's proprietary validator infrastructure is engineered to maximize uptime, enhance network security, and contribute to the resilience of Ethereum's core protocol. To power its long-term blockchain operations, the Company maintains ETH as its primary treasury asset and seeks to scale its holdings in line with its infrastructure growth.
The new name, Republic, reflects the Company's broader commitment to decentralization, transparency, and democratized access to secure systems. Inspired by the philosophical foundations of Plato's Socratic dialogue, the name signals Republic's long-term vision of building a more inclusive and equitable digital economy.
The Company's common shares will continue to trade on the Canadian Securities Exchange under the ticker symbol "DOCT". The Company is in the process of updating its website, corporate materials, and regulatory filings to reflect the new name.
About Republic Technologies Inc.
Republic Technologies is a publicly traded technology company integrating Ethereum infrastructure into the global economy. The company develops smart contract-based products, utilizes ETH as its primary treasury asset, and operates proprietary validator infrastructure to deliver sustainable, non-dilutive value to shareholders.
On behalf of the Board of Directors
Daniel Liu, Chief Executive Officer
Email: daniel@beyond-md.co
Neither the Canadian Securities Exchange nor its Regulation Services Provider has reviewed or accepts responsibility for the accuracy or adequacy of this release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/258990
FAQ
Why did Beyond Medical Technologies (CSE: DOCT) change its name to Republic Technologies?
When is Republic Technologies' name change effective?
What is Republic Technologies' main business focus?
Will Republic Technologies' stock symbol change after the name change?
What are the new CUSIP and ISIN numbers for Republic Technologies?
